Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms

Ki vehet részt

• The patient is under consultation in the department of metabolic and endocrine disorders at the CHU Nimes for diagnosis or follow-up of hypercortisol assessment
• The patient must be a member or beneficiary of a health insurance plan

Ki nem vehet részt

• The patient has a cardiovascular or metabolic state against the indication of dexamethasone; Patient with DFG < 30 ml/min/1.73 m2
• The subject is in a period of exclusion determined by a previous study
• The patient is pregnant, parturient or breastfeeding
• The patient has suffered urinary incontinence rendering 24-hour urinary collection impossible or non-interpretable
• The patient has a urinary catheter
• The patient is taking corticoids (oral, inhaled, intra-venous or cutaneous); .Patient exposed to interfering treatments (Itraconazole, ritonavir, megestrol acetate, medroxyprogesterone acetate, TSH, estrogen-progestogen pill, hormonal coil)
• The subject opposes their participation in the study
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship